Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies

Blood

Volumn 100, Issue 13, 2002, Pages 4521-4528

  Hebart, Holger ^a,b,c,d,e   Bollinger, Claudia ^a,b,c,d   Fisch, Paul ^a,b,c,d   Sarfati, Jacqueline ^a,b,c,d   Meisner, Christoph ^a,b,c,d   Baur, Manuela ^a,b,c,d   Loeffler, Jürgen ^a,b,c,d   Monod, Michel ^a,b,c,d   Latgé, Jean Paul ^a,b,c,d   Einsele, Hermann ^a,b,c,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c INSTITUT PASTEUR   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e II Medizinische Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; DIPEPTIDYL PEPTIDASE; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL CLONE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMATOLOGIC MALIGNANCY; HOST RESISTANCE; HUMAN; LYMPHOCYTE PROLIFERATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

EID: 0037114694     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0265     Document Type: Article

References (35)

1. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis. 1997;175:1459-1466.
2. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med. 1997;185:207-18.
3. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest. 1982;69:617-631.
4. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984;100:345-351.
5. Addrizzo-Harris DJ, Harkin TJ, McGuinness G, Naidich DP, Rom WN. Pulmonary aspergillosis and AIDS. A comparison of HIV-infected and HIV-negative individuals. Chest. 1997;111:612-618.
6. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991;324:654-662.
7. Groll AH, Jaeger G, Allendorf A, Herrmann G, Schloesser R, von Loewenich V. Invasive pulmonary aspergillosis in a critically ill neonate: Case report and review of invasive aspergillosis during the first 3 months of life. Clin Infect Dis. 1998;27:437-452.
8. Offner F, Cordonnier C, Ljungman P, et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis. 1998;26:1098-1103.
9. Einsele H, Quabeck K, Müller KD, et al. Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation. Lancet. 1998;352:1443.
10. Cenci E, Mencacci A, Fe d'Ostiani C et al. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis. 1998;178:1750-1760.
11. Romani L. The T cell response against fungal infections. Curr Opin Immunol. 1997;9:484-490.
12. Cenci E, Mencacci A, Del Sero G, et al. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis. 1999;180:1957-1968.
13. Mehrad B, Strieter RM, Standiford TJ. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. J Immunol. 1999;162:1633-1640.
14. Cenci E, Perito S, Enssle KH, et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 1997;65:564-570.
15. Cenci E, Mencacci A, Bacci A, Bistoni F, Kurup WP, Romani L. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 2000;165:381-388.
16. Beauvais A, Monod M, Debeaupuis JP, Diaquin M, Kobayashi H, Latge JP. Biochemical and antigenic characterization of a new dipeptidyl-peptidase isolated from Aspergillus fumigatus. J Biol Chem. 1997;272:6238-6244
17. Calera JA, Paris S, Monod M, et al. Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus. Infect Immun. 1997;65:4718-4724.
18. Krause H, Hebart H, Jahn G, Müller CA, Einsele H. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant. 1997;19:1111-1116.
19. Fisch P, Meuer E, Pende D, et al. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/ Vdelta2 T cells in tumor immunity. Eur J Immunol. 1997;27:3368-3379.
20. Viale O, van der Bruggen P, Meuer E, et al. Recognition by human Vgamma9/Vdelta2 T cells of melanoma cells upon fusion with Daudi cells. Immunogenetics. 1996;45:27-34.
21. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis. 2002;34:7-14.
22. Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12:310-350.
23. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect. 1996;33:23-32.
24. Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax., 1991;46:15-20.
25. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood. 2001;97:3380-3389.
26. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today. 1994;15:575-581.
27. Clemons KV, Grunig G, Sobel RA, Mirels LF, Rennick DM, Stevens DA. Role of IL-10 in invasive aspergillosis: Increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol. 2000;122:186-191.
28. Grazziutti ML, Rex JH, Cowart RE, Anaissie EJ, Ford A, Savary CA. Aspergillus fumigatus conidia induce a Th1-type cytokine response. J Infect Dis. 1997;176:1579-1583.
29. Roilides E, Sein T, Roden M, Schaufele RL, Walsh TJ. Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis: J Infect Dis. 2001:183:518-520.
30. Constant P, Davodeau F, Peyrat MA, et al. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science. 1994;264:267-270.
31. De Libero G, Casorati G, Giachino C, et al. Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells. J Exp Med. 1991;173:1311-1322.
32. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature. 1995;375:155-158.
33. +/V delta 2-T-cell receptor gamma/delta T cells early after bone marrow transplantation. Blood. 1991;78:1875-1881.
34. Cela ME, Holladay MS, Rooney CM, et al. Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors. Bone Marrow Transplant. 1996;17:243-247.
35. Morita CT, Lee HK, Wang H, Li H, Mariuzza RA, Tanaka Y. Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells. J Immunol. 2001;167:36-41.